Apimeds Pharmaceuticals US APUS SEC Filings

NYSE APUS
$3.09 -0.33 (-9.53%)
As of: Oct 21, 2026 · 1:27 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Apimeds Pharmaceuticals US, Inc. (APUS) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001213900-26-108780Oct 13, 2026 5:10 PM
28-KCurrent Report0001213900-26-105484Oct 1, 2026 9:15 AM
38-KCurrent Report0001213900-26-104668Sep 29, 2026 4:15 PM
48-KCurrent Report0001213900-26-102321Sep 23, 2026 12:18 AM
58-KCurrent Report0001213900-26-099002Sep 11, 2026 9:10 AM
68-KCurrent Report0001213900-26-092680Aug 21, 2026 9:12 PM
710-QQuarterly & Annual Report0001213900-26-090120Aug 14, 2026 8:22 PM
88-KCurrent Report0001213900-26-086244Aug 6, 2026 9:25 PM
98-KCurrent Report0001213900-26-077591Jul 13, 2026 8:30 PM
1010-QQuarterly & Annual Report0001213900-26-061013May 26, 2026 4:05 PM-
11NT 10-QQuarterly & Annual Report0001213900-26-057713May 15, 2026 8:05 PM
12SCHEDULE 13DBeneficial Ownership Report0001213900-26-053091May 7, 2026 1:11 PM
13SCHEDULE 13DBeneficial Ownership Report0001213900-26-053091May 7, 2026 1:11 PM
14SCHEDULE 13DBeneficial Ownership Report0001213900-26-053091May 7, 2026 1:11 PM
158-KCurrent Report0001213900-26-052036May 5, 2026 12:30 PM
1610-KQuarterly & Annual Report0001213900-26-051139May 4, 2026 10:57 AM
178-KCurrent Report0001213900-26-051125May 4, 2026 10:15 AM
188-KCurrent Report0001213900-26-046671Apr 22, 2026 5:06 PM
198-KCurrent Report0001213900-26-044657Apr 16, 2026 8:30 PM
20425Others0001213900-26-042030Apr 9, 2026 8:36 PM
218-KCurrent Report0001213900-26-042017Apr 9, 2026 8:30 PM
22NT 10-KQuarterly & Annual Report0001213900-26-037575Mar 31, 2026 8:57 PM
23SCHEDULE 13DBeneficial Ownership Report0001213900-26-035996Mar 30, 2026 12:20 PM
248-KCurrent Report0001213900-26-034786Mar 26, 2026 8:46 PM
258-KCurrent Report0001213900-26-033832Mar 25, 2026 11:00 AM
26SCHEDULE 13DBeneficial Ownership Report0001213900-26-032480Mar 20, 2026 10:21 PM
278-KCurrent Report0001213900-26-028332Mar 16, 2026 8:30 PM
28DEFM14COthers0001213900-26-020883Feb 27, 2026 10:49 PM
29425Others0001213900-26-017331Feb 17, 2026 9:31 PM
308-KCurrent Report0001213900-26-017323Feb 17, 2026 9:30 PM
31SCHEDULE 13GBeneficial Ownership Report0001493152-26-006136Feb 11, 2026 2:51 PM
32SCHEDULE 13DBeneficial Ownership Report0001213900-26-007438Jan 26, 2026 11:03 AM
33PREM14COthers0001213900-26-005174Jan 16, 2026 9:35 PM
348-KCurrent Report0001213900-26-000464Jan 2, 2026 9:30 PM
358-KCurrent Report0001213900-25-119894Dec 10, 2025 2:20 PM
368-KCurrent Report0001213900-25-119893Dec 10, 2025 2:18 PM
37425Others0001213900-25-117176Dec 2, 2025 8:16 PM
388-KCurrent Report0001213900-25-117173Dec 2, 2025 8:12 PM
394Insider Transaction0002057997-25-000002Nov 21, 2025 2:26 AM
408-KCurrent Report0001213900-25-112184Nov 18, 2025 9:57 PM
414Insider Transaction0002040378-25-000004Nov 13, 2025 11:43 PM
424Insider Transaction0002040378-25-000004Nov 13, 2025 11:43 PM
434Insider Transaction0002040378-25-000004Nov 13, 2025 11:43 PM
444Insider Transaction0002041300-25-000003Nov 13, 2025 11:39 PM
454Insider Transaction0002041300-25-000003Nov 13, 2025 11:39 PM
464Insider Transaction0002041300-25-000003Nov 13, 2025 11:39 PM
474Insider Transaction0002041972-25-000004Nov 13, 2025 11:37 PM
484Insider Transaction0002041972-25-000004Nov 13, 2025 11:37 PM
494Insider Transaction0002041972-25-000004Nov 13, 2025 11:37 PM
504Insider Transaction0001573840-25-000003Nov 13, 2025 11:34 PM

Apimeds Pharmaceuticals US, Inc. SEC Filings API

Pull Apimeds Pharmaceuticals US, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=APUS&formtype=10-K,10-Q&api_key=YOUR_API_KEY